In today's world, POLR2B is a topic that has gained great relevance and interest in society. Whether due to its implications in daily life, its impact in the workplace or its influence on technological development, POLR2B has captured the attention of different sectors and has sparked numerous debates and discussions. Over time, POLR2B has become a fundamental element that not only sparks curiosity, but also poses challenges and opportunities for the future. In this article, we will explore different aspects of POLR2B, analyzing its importance, its evolution and its potential to transform various areas of society.
DNA-directed RNA polymerase II subunit RPB2 is an enzyme that in humans is encoded by the POLR2Bgene.[5][6]
This gene encodes the second largest subunit of RNA polymerase II, the polymerase responsible for synthesizing messenger RNA in eukaryotes. This subunit, in combination with at least two other polymerase subunits, forms a structure within the polymerase that maintains contact in the active site of the enzyme between the DNA template and the newly synthesized RNA.[7]
^"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^Acker J, Wintzerith M, Vigneron M, et al. (October 1992). "Primary structure of the second largest subunit of human RNA polymerase II (or B)". J Mol Biol. 226 (4): 1295–9. doi:10.1016/0022-2836(92)91071-V. PMID1518060.
^Acker J, Mattei MG, Wintzerith M, et al. (August 1994). "Chromosomal localization of human RNA polymerase II subunit genes". Genomics. 20 (3): 496–9. doi:10.1006/geno.1994.1208. PMID8034326.
Harrich D, McMillan N, Munoz L, et al. (2007). "Will diverse Tat interactions lead to novel antiretroviral drug targets?". Current Drug Targets. 7 (12): 1595–606. doi:10.2174/138945006779025338. PMID17168834.
Agostini I, Navarro JM, Rey F, et al. (1996). "The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB". J. Mol. Biol. 261 (5): 599–606. doi:10.1006/jmbi.1996.0485. PMID8800208.